back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-02 10:47 Tx date 2025-08-29 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+187,500 vol |
259,000 | |
| Filed 2025-09-02 10:46 Tx date 2025-08-29 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+187,500 vol $0.40 each |
4,935,500 | |
| Filed 2023-12-27 23:44 Tx date 2023-12-08 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$85,000 vol $10.00 each |
$85,000 | |
| Filed 2023-12-08 14:41 Tx date 2023-12-08 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$8,500 vol $10.00 each |
||
| Filed 2023-12-08 14:41 Tx date 2023-12-08 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$8,500 vol $10.00 each |
$8,500 | |
| Filed 2023-12-08 14:35 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-03 23:54 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
4,748,000 |